EUROMEDIX
The computed 12-month bankruptcy probability of EUROMEDIX is 0.3% (very low). The 2025 annual accounts show equity of €982k and a net result of €-344. Equity remains stable across the filed fiscal years (±0.1% per year). Its solvency ranks better than 87% of 335 sector peers (fiscal year 2025). The company has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €982k |
| Net result | €-344 |
| Better than sector | 87% |
| Active | 31 yrs |
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 81.6% | 35.1% | |
| Net result | €-344 | €42k | |
| Equity | €982k | €278k | |
| Gross operating margin | €33k | €240k | |
| Total assets | €1.20M | €1.22M |
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €3k |
| Net profit | €-344 |
| Cash flow | €3k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €1.20M |
| Equity | €982k |
| Debt | €202k |
| of which ≤ 1y | €202k |
| of which > 1y | - |
| Working capital | €-52k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.74 |
| Quick ratio | 0.74 |
| Working capital ratio | -4.3% |
| Solvency | 81.6% |
| Debt / equity | 0.21 |
| Long-term debt ratio | - |
| Interest coverage | 6.42 |
| Gross margin | - |
| Net margin | - |
| ROA | 0.0% |
| ROE | 0.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.20M |
| Fixed assets | 21/28 | €1.05M |
| Tangible fixed assets | 22/27 | €1.05M |
| Financial fixed assets | 28 | €93 |
| Current assets | 29/58 | €150k |
| Amounts receivable within one year | 40/41 | €149k |
| Cash & bank | 54/58 | €326 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.20M |
| Equity | 10/15 | €982k |
| Contributions / capital | 10/11 | €62k |
| Reserves | 13 | €132k |
| Accumulated profits (losses) | 14 | €8k |
| Provisions & deferred taxes | 16 | €20k |
| Amounts payable | 17/49 | €202k |
| Amounts payable within one year | 42/48 | €202k |
| Trade debts payable within one year | 44 | €38k |
| Income statement | ||
| Gross operating margin | 9900 | €33k |
| Operating result | 9901 | €125 |
| Financial charges | 65 | €470 |
| Result before taxes | 9903 | €-344 |
| Net result for the period | 9904 | €-344 |
| Result to be appropriated | 9905 | €-344 |
| NACE primary | Niet-gespecialiseerde groothandel(46900) |
| Legal form | Public limited company(014) |
| Incorporation | 21-06-1995 |
| Status | Active |
| Postal code | 3018 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24038C0158/00C000 | Flanders | 1.5 ha | 1 · 3,050 m² | 8.8 m · 2 fl. |
| 24038C0156/00C000indicative | Flanders | 365 m² | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
16-02-2024 Restructuring of share classes
Technical details
{
"events": [
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Jan Coppens",
"firm_city": null,
"firm_name": null,
"office_city": "Vosselaar",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-16",
"filing_date": "2024-02-07",
"act_kind_objet": "OMZETTING AANDELEN AAN TOONDER IN AANDELEN OP NAAM - ONTSLAG BESTUURDERS EN BENOEMING ENIGE BESTUURDER - AANPASSING VAN DE STATUTEN AAN DE BEPALINGEN VAN HET WET-BOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-11-27",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0455.466.864",
"name_full": "EUROMEDIX",
"legal_form": "naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"akte",
"lijst publicatiedata",
"gestateerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | EUROMEDIX |